Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:569-575
doi: 10.1161/hy09t1.095393
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bezerra, S. M.M.S.
Right arrow Articles by Michelini, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bezerra, S. M.M.S.
Right arrow Articles by Michelini, L. C.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow ACE/Angiotension receptors
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2001;38:569.)
© 2001 American Heart Association, Inc.


Neurogenic Factors

Chronic AT1 Receptor Blockade Alters Autonomic Balance and Sympathetic Responses in Hypertension

Simone M.M.S. Bezerra; Claudia M. dos Santos; Edson D. Moreira; Eduardo M. Krieger; Lisete C. Michelini

Department of Physiology and Biophysics, ICB (S.M.M.S.B., C.M.d.S., L.C.M.) and Heart Institute (E.D.M., E.M.K.), University of São Paulo, São Paulo, SP, Brazil.

Correspondence to Lisete C. Michelini, PhD, Department of Physiology and Biophysics, Institute of Biomedical Sciences, USP, Av. Prof. Lineu Prestes, 1524, 05508-900 Sao Paulo, SP, Brazil. E-mail michelin{at}usp.br

Abstract

Abstract— In the coarctation hypertension model, we have shown that chronic treatment with losartan causes both normalization of impaired reflex control of heart rate and partial correction of the depressed aortic nerve activity/pressure relationship, even with the persistence of hypertension. In the present study, we analyzed the effects of angiotensin II blockade on the efferent pathways of coarcted and sham-operated groups treated chronically with vehicle or losartan (10 mg/kg per day PO). Hypertension was induced by subdiaphragmatic aortic coarctation, and the treatments lasted 9 days (4 control and 5 experimental days). On day 5, autoregressive power spectral analysis was performed on heart rate recordings made in conscious rats. Other groups were used for sympathetic splanchnic nerve activity recordings made simultaneously with pressure (anesthetized rats) at basal condition and during loading/unloading of baroreceptors. Losartan treatment induced a significant reduction in basal pressure but did not interfere with the development of hypertension (similar pressure increases of 24% and 28% over control values in losartan and vehicle groups, respectively). In vehicle-treated rats, establishment of hypertension was accompanied by a marked change in power spectral density from high- (1.19±0.06 Hz, 33±6%) to low-frequency components (0,42±0.03 Hz, 54±6%), with increased low-frequency–to–high-frequency ratio. When compared with sham-operated vehicle-treated rats, there was also increase in the gain of sympathetic activity/pressure relationship, with displacement of lower plateau toward high levels of sympathetic activity. No changes in the power spectral density and sympathetic activity/pressure relationship were observed when hypertension developed in the presence of chronic angiotensin type 1 (AT1) receptor blockade. The data suggest that angiotensin II, activated during the establishment of coarctation hypertension, acts via AT1 receptors to alter sympathovagal balance, facilitating the sympathetic outflow to heart and peripheral circulation during baroreceptors unloading. Data also indicate that the observed effects are not conditioned by preexisting pressure levels.


Key Words: receptors, angiotensin II • losartan • blood pressure • heart rate • hypertension, experimental • rats




This article has been cited by other articles:


Home page
HypertensionHome page
A. C. da Costa-Goncalves, J. Tank, R. Plehm, A. Diedrich, M. Todiras, M. Gollasch, A. Heuser, M. Wellner, M. Bader, J. Jordan, et al.
Role of the Multidomain Protein Spinophilin in Blood Pressure and Cardiac Function Regulation
Hypertension, October 1, 2008; 52(4): 702 - 707.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Brili, D. Tousoulis, C. Antoniades, C. Vasiliadou, M. Karali, N. Papageorgiou, N. Ioakeimidis, K. Marinou, E. Stefanadi, and C. Stefanadis
Effects of Ramipril on Endothelial Function and the Expression of Proinflammatory Cytokines and Adhesion Molecules in Young Normotensive Subjects With Successfully Repaired Coarctation of Aorta A Randomized Cross-Over Study.
J. Am. Coll. Cardiol., February 19, 2008; 51(7): 742 - 749.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. V. C. Felix and L. C. Michelini
Training-Induced Pressure Fall in Spontaneously Hypertensive Rats Is Associated With Reduced Angiotensinogen mRNA Expression Within the Nucleus Tractus Solitarii
Hypertension, October 1, 2007; 50(4): 780 - 785.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Nishikino, T. Matsunaga, K. Yasuda, T. Adachi, T. Moritani, G. Tsujimoto, K. Tsuda, and N. Aoki
Genetic Variation in the Renin-Angiotensin System and Autonomic Nervous System Function in Young Healthy Japanese Subjects
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4676 - 4681.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Chen, L. F. Joaquim, V. M. Farah, R. B. Wichi, R. Fazan Jr., H. C. Salgado, and M. Morris
Cardiovascular autonomic control in mice lacking angiotensin AT1a receptors
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R1071 - R1077.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. T. Sangaleti, A. Crescenzi, and L. C. Michelini
Endogenous Angiotensin and Pressure Modulate Brain Angiotensinogen and AT1A mRNA Expression
Hypertension, February 1, 2004; 43(2): 317 - 323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. C. Michelini, M. C. Marcelo, J. Amico, and M. Morris
Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2269 - H2276.
[Abstract] [Full Text] [PDF]